AB
The startup develops a molecular diagnostic device that rapidly detects COVID-19 and other viruses from a single sample within minutes. This technology enables healthcare providers to achieve early virus detection and facilitates the submission of test results by patients as needed.
Updated 3 months ago
Funding
$6.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops a molecular diagnostic device that rapidly detects COVID-19 and other viruses from a single sample within minutes. This technology enables healthcare providers to achieve early virus detection and facilitates the submission of test results by patients as needed.